Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan

Overview of attention for article published in Frontiers in Pharmacology, October 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 6 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 8,604 followers.

RT @VPH_Institute: #insilicoliterature 📖 The authors created a computer model that simulates how dextromethorphan (DXM) and its byproducts…

14 Jun 2023

Reply Repost Favourite

#insilicoliterature 📖 The authors created a computer model that simulates how dextromethorphan (DXM) and its byproducts are processed in the body, and that is able to accurately predict how different genetic variations and enzyme activities affect the meta

14 Jun 2023

Reply Repost Favourite

New Research: Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan https://t.co/XsFottdZpP #pharmacology

25 Oct 2022

Reply Repost Favourite

RT @konigmatt: How does CYP2D6 genotype effect metabolic phenotyping? See our latest paper for some answers. Amazing work by @JanekG9 using…

24 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.